Overview
- 5 inspections across 5 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-06-17.
At a glance
Inspections
5
Sites
5
Observations
0
Career since
Mar 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Clongen Laboratories LLC | 17 Jun 2025 | Biologics | On file |
| Janssen Pharmaceuticals Inc. | 1 Nov 2024 | Biologics | On file |
| Pfizer Manufacturing Belgium NV | 28 Jun 2024 | Biologics | |
| Wyeth Pharmaceutical Division of Wyeth Holdings LLC | 10 Nov 2023 | Biologics | On file |
| Catalent Maryland Inc | 10 Mar 2023 | Biologics | On file |
Sites inspected
Clongen Laboratories LLCGaithersburg, United States1 insp.
Janssen Pharmaceuticals Inc.Raritan, United States1 insp.
Pfizer Manufacturing Belgium NVPuurs-Sint-Amands, Belgium1 insp.
Wyeth Pharmaceutical Division of Wyeth Holdings LLCSanford, United States1 insp.
Catalent Maryland IncHarmans, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Carl A Perez2 shared
Hyesuk Kong1 shared
Donald B Ertel1 shared
Xiuju Lu1 shared
Wei Wang1 shared
Ronit Jolles-Mazor1 shared
Grace I Cortesini1 shared
Sukyoung Sohn1 shared
Viviana R Ramirez1 shared
Jianyang Wang1 shared
Full investigator report
Get the verbatim findings behind Kevin J Matthews' inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site